MINNEAPOLIS, Aug. 11 /EMWNews/ -- Uroplasty, Inc. (Amex:

UPI) announced today that it will present at the at the upcoming Noble

Financial Fourth Annual Equity Conference which will be held Monday, August

18th - Tuesday, August 19th, 2008 at the Loews Lake Las Vegas Resort, NV.

Dave Kaysen, President and Chief Executive Officer and Medi Jiwani, Vice

President and Chief Financial Officer will discuss the Company's business

strategy and historical financial performance at 9:30 a.m. Pacific Time on

Monday, August 18th.



    A live audio webcast of Uroplasty's presentation may be accessed

through the Company's website at http://www.uroplasty.com. An archived

replay of the presentation will be available after the live presentation,

and can also be accessed at http://www.uroplasty.com.

    About Uroplasty, Inc.



    Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with

wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a

medical device company that develops, manufactures and markets innovative

proprietary products for the treatment of voiding dysfunctions. Our primary

focus is the commercialization of our Urgent PC system, which we believe is

the only FDA-approved minimally invasive nerve stimulation device designed

for office-based treatment of urinary urgency, urinary frequency and urge

incontinence -- symptoms often associated with overactive bladder. We also

offer Macroplastique(R) Implants, an injectable bulking agent for the

treatment of adult female stress urinary incontinence pimarily due to

intrinsic sphincter deficiency. Please visit Uroplasty, Inc. at

http://www.uroplasty.com.






     For Further Information:

     Uroplasty, Inc.                         EVC Group

     David Kaysen, President and CEO, or     Dahlia Bailey (Investors)

     Medi Jiwani, Vice President, CFO,       415.896.5862

     and Treasurer,

     952.426.6140                            Steve DiMattia/Chris Gale (Media)

                                             646.201.5445